EYAL MUSCAL to Cohort Studies
This is a "connection" page, showing publications EYAL MUSCAL has written about Cohort Studies.
Connection Strength
0.206
-
Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution. Lupus. 2010 Mar; 19(3):268-79.
Score: 0.043
-
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.
Score: 0.023
-
Anakinra usage in febrile infection related epilepsy syndrome: an international cohort. Ann Clin Transl Neurol. 2020 12; 7(12):2467-2474.
Score: 0.023
-
Infectious and Autoimmune Causes of Encephalitis in Children. Pediatrics. 2020 06; 145(6).
Score: 0.022
-
Health-related quality of life in children with inflammatory brain disease. Pediatr Rheumatol Online J. 2018 Nov 20; 16(1):73.
Score: 0.020
-
Clinical presentation and outcomes of childhood-onset membranous lupus nephritis. Pediatr Nephrol. 2017 Dec; 32(12):2283-2291.
Score: 0.018
-
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016 10; 68(10):2514-26.
Score: 0.017
-
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014 Jul 08; 83(2):142-50.
Score: 0.015
-
Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol. 2012 May; 39(5):1088-94.
Score: 0.013
-
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum. 2009 Nov; 60(11):3413-24.
Score: 0.011